Literature DB >> 32242233

Burden of Peripheral Artery Disease on Mortality and Incident Cardiovascular Events.

Jonathan T Unkart, Matthew A Allison, Maria Rosario G Araneta, Joachim H Ix, Kunihiro Matsushita, Michael H Criqui.   

Abstract

Using data from the Multi-Ethnic Study of Atherosclerosis (United States, 2000-2015), 6,527 racially/ethnically diverse adults (mean age, 62 (standard deviation, 10) years) free of known cardiovascular (CVD) had ankle brachial index (ABI) assessment of their bilateral dorsalis pedis/posterior tibial arteries (4 vessels total) and were followed for total mortality and incident CVD events/mortality. Individuals were classified into categories of 0-, 1-, 2-, 3- or 4-vessel peripheral artery disease (PAD) (ABI of ≤0.9). There were 1,202 deaths (18%), 656 incident CVD events (10%), and 282 CVD deaths (4.3%). Of the 6,527 individuals, 5,711 (87.5%) had 0-, 460 (7.0%) had 1-, 218 (3.3%) had 2-, 69 (1.1%) had 3-, and 69 (1.1%) had 4-vessel PAD, respectively. In multivariable Cox models, higher number of vessels with PAD was associated with higher risk of mortality (P for trend <0.001), CVD events (P for trend = 0.002), and CVD mortality (P for trend = 0.001). Compared with individuals who had 0-vessel disease, hazard ratios for mortality were 1.29 (95% confidence interval (CI): 1.06, 1.59) for 1-, 1.45 (95% CI: 1.14, 1.86) for 2-, 1.58 (95% CI: 1.13, 2.21) for 3-, and 2.15 (95% CI: 1.58, 2.94) for 4-vessel disease. A similar pattern was seen for CVD events/mortality. These results suggest the importance of accounting for ABI values of all 4 leg arteries in clinical practice and research.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ankle brachial index; claudication; multivessel; primary prevention; screening

Mesh:

Year:  2020        PMID: 32242233      PMCID: PMC7607965          DOI: 10.1093/aje/kwaa051

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  29 in total

1.  Moderate physical activity patterns of minority women: the Cross-Cultural Activity Participation Study.

Authors:  B E Ainsworth; M L Irwin; C L Addy; M C Whitt; L M Stolarczyk
Journal:  J Womens Health Gend Based Med       Date:  1999 Jul-Aug

2.  Statins for Prevention of Cardiovascular Events in a Low-Risk Population With Low Ankle Brachial Index.

Authors:  Rafel Ramos; Maria García-Gil; Marc Comas-Cufí; Miquel Quesada; Jaume Marrugat; Roberto Elosua; Joan Sala; María Grau; Ruth Martí; Anna Ponjoan; Lia Alves-Cabratosa; Jordi Blanch; Bonaventura Bolíbar
Journal:  J Am Coll Cardiol       Date:  2016-02-16       Impact factor: 24.094

3.  The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing.

Authors:  M H Criqui; J O Denenberg; C E Bird; A Fronek; M R Klauber; R D Langer
Journal:  Vasc Med       Date:  1996       Impact factor: 3.239

4.  Abdominal aortic calcium, coronary artery calcium, and cardiovascular morbidity and mortality in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Michael H Criqui; Julie O Denenberg; Robyn L McClelland; Matthew A Allison; Joachim H Ix; Alan Guerci; Kevin P Cohoon; Preethi Srikanthan; Karol E Watson; Nathan D Wong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-08       Impact factor: 8.311

5.  Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction.

Authors:  Christine Espinola-Klein; Hans J Rupprecht; Christoph Bickel; Karl Lackner; Savvas Savvidis; Claudia M Messow; Thomas Munzel; Stefan Blankenberg
Journal:  Circulation       Date:  2008-08-12       Impact factor: 29.690

6.  Alternative ankle-brachial index method identifies additional at-risk individuals.

Authors:  Kevin T Nead; John P Cooke; Jeffrey W Olin; Nicholas J Leeper
Journal:  J Am Coll Cardiol       Date:  2013-05-22       Impact factor: 24.094

7.  The relevance of different methods of calculating the ankle-brachial index: the multi-ethnic study of atherosclerosis.

Authors:  Matthew A Allison; Victor Aboyans; Tanya Granston; Mary M McDermott; Aruna Kamineni; Hanyu Ni; Michael H Criqui
Journal:  Am J Epidemiol       Date:  2009-12-30       Impact factor: 4.897

8.  Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement.

Authors:  Susan J Curry; Alex H Krist; Douglas K Owens; Michael J Barry; Aaron B Caughey; Karina W Davidson; Chyke A Doubeni; John W Epling; Alex R Kemper; Martha Kubik; C Seth Landefeld; Carol M Mangione; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2018-07-10       Impact factor: 56.272

9.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

10.  The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

Authors:  Jill Belch; Angus MacCuish; Iain Campbell; Stuart Cobbe; Roy Taylor; Robin Prescott; Robert Lee; Jean Bancroft; Shirley MacEwan; James Shepherd; Peter Macfarlane; Andrew Morris; Roland Jung; Christopher Kelly; Alan Connacher; Norman Peden; Andrew Jamieson; David Matthews; Graeme Leese; John McKnight; Iain O'Brien; Colin Semple; John Petrie; Derek Gordon; Stuart Pringle; Ron MacWalter
Journal:  BMJ       Date:  2008-10-16
View more
  1 in total

1.  Implications of fasting plasma glucose variability on the risk of incident peripheral artery disease in a population without diabetes: a nationwide population-based cohort study.

Authors:  Hye Soo Chung; Soon Young Hwang; Jung A Kim; Eun Roh; Hye Jin Yoo; Sei Hyun Baik; Nan Hee Kim; Ji A Seo; Sin Gon Kim; Nam Hoon Kim; Kyung Mook Choi
Journal:  Cardiovasc Diabetol       Date:  2022-01-31       Impact factor: 9.951

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.